Neurotech International (NTI) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free NTI Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNeurotech’s Phase 2/3 autism trial meets primary endpointmsn.com - April 17 at 2:10 PMNeurotech hits new milestone in Phase II/III autism trial after treating last patientmsn.com - April 10 at 1:37 AMNeuroVigil, World's Most Valuable Neurotech, Launches iBrain™ in UStmcnet.com - April 5 at 3:30 PMNeuroVigil, World's Most Valuable Neurotech Company, Launches in UStmcnet.com - April 5 at 12:28 AMNeurotech extends clinical trials for the $US2bn Rett Syndrome marketmsn.com - March 13 at 5:47 AMNeurotech International's (ASX:NTI) investors will be pleased with their massive 340% return over the last five yearsfinance.yahoo.com - February 27 at 8:55 PMMarket Highlights: Chipmaker Arm up 29pc, Bitcoin tops US$50k, and 5 ASX small caps to watch todaymsn.com - February 13 at 2:13 AMMicroPort NeuroTech Ltd 02172morningstar.com - February 7 at 10:34 PMNeurotech gets green light to start phase I/II cerebral palsy trialmsn.com - January 28 at 11:40 PMNeurotech moves to show economic advantage of autism treatment as Phase II/III trial results due soonmsn.com - January 24 at 10:54 PMWhat’s in store for 2024: Neurotech Internationalmsn.com - January 16 at 2:39 PMPart 1: ASX biotechs with catalysts looking to pop in 2024msn.com - December 26 at 9:23 AMNeurotech completes recruitment in Phase 2/3 autism spectrum disorder trialmsn.com - December 18 at 9:16 PMNeurotech to extend Phase 2/3 autism spectrum disorder trial to adultsmsn.com - December 3 at 10:55 PMNeurotech treatment looks to be making a difference in children with PANDAS/PANS in Phase I/II clinical trialmsn.com - October 8 at 9:41 AMMotif Neurotech Conducts First-in-human Brain Stimulation With Millimeter-sized Implantable Device for Treatment-resistant Depressionbusinesswire.com - September 22 at 8:52 AMNorthern Trust Asset Management Names New CIO of Global Asset Allocationbenzinga.com - September 7 at 4:13 PMMoneyTalks: Merchant Group’s Andrew Chapman has his eye on these diagnostic biotech stocksmsn.com - August 14 at 7:14 AMHere's Why We're Not Too Worried About Neurotech International's (ASX:NTI) Cash Burn Situationfinance.yahoo.com - June 27 at 9:51 AMNeurotech International Ltd (NTI)uk.investing.com - June 21 at 8:49 AMASX Health Stocks: Neurotech says NTI164 works well in 11 autistic children after 52 weeks of treatmentmsn.com - March 17 at 7:37 AMArovella Therapeutics recruits biotech stalwart as non-executive chairproactiveinvestors.com.au - March 12 at 9:53 PMNeurotech International Limited (NTI.AX)au.finance.yahoo.com - January 15 at 8:57 AMNeurotech Devices Market is projected to grow at a CAGR of 13.78% by 2033: Visiongain Reports Ltdbenzinga.com - January 14 at 11:45 PMWe Think Neurotech International (ASX:NTI) Needs To Drive Business Growth Carefullyfinance.yahoo.com - January 14 at 11:45 PMNeurotech Devices: Global Market Outlookyahoo.com - January 13 at 12:35 AMNorthern Technologies International Corporation (NTIC) Q1 2023 Earnings Call Transcriptseekingalpha.com - January 12 at 2:34 PM Get Neurotech International News Delivered to You Automatically Sign up to receive the latest news and ratings for NTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now NTI Media Mentions By Week NTI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTI News Sentiment▼0.320.43▲Average Medical News Sentiment NTI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTI Articles This Week▼00▲NTI Articles Average Week Get Neurotech International News Delivered to You Automatically Sign up to receive the latest news and ratings for NTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cell MedX News Cochlear News Evome Medical Technologies News GN Store Nord A/S News Hamilton Thorne News Heart Test Laboratories News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:NTI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotech International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
